FDA reminds health care facilities to use proper N95 sterilization processes
The Food and Drug Administration yesterday issued a reminder to health care facilities’ reprocessing staffs to follow the agency-outlined decontamination cycle when using the ASP STERRAD Sterilization System to decontaminate N95 or N95-equivalent respirators for reuse via vaporized hydrogen peroxide.
FDA April 11 authorized the device’s emergency use for the duration of the COVID-19 pandemic.
To ensure continued safe use of the device, the agency is repeating its sterilization process recommendations, which include material and cycle consideration, as well as agency-developed instructions and a fact sheet.
Related News Articles
Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…